Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Teitell
University of California Los Angeles, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
NanoCav LLC
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Teitell is the PI and a consultant and a founder of the company.
Reverse Mitochondrial Genetics Enabled by Blast
This proposal is relevant to public health because it will open a blocked translational field by enabling the purposeful sequence alterations of maternally inherited mitochondrial DNA (mtDNA) to overcome or compensate for mutations that cause > 200 named human disease syndromes. In addition, success in this proposal will also enable so-called mitochondrial reverse genetics, which would allow new knowledge for how specific sequence changes in mtDNA affect cell functions including respiration, metabolism, survival, and proliferation. Our preliminary studies support a wealth of new, unexpected findings from these studies as we have already discovered that retrograde signaling from mitochondria with repaired mtDNA can correct a defect in the translation or stability of a metabolic enzyme that is encoded within the nucleus of a cell, to fix integrated cellular circuits that control cell metabolism.
Filed on April 25, 2017.
Tell us what you know about Michael Teitell's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael Teitell filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav, LLC | $10,000 - $19,999 |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav, LLC | $0 - $4,999 |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav LLC | Value cannot be readily determined |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav LLC | Value cannot be readily determined |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.